Lishan Aklog Insider Profile
11 Followers
Lishan Aklog, Chairman & CEO, Director at PAVmed, holds 367.57K shares in PAVmed (Ticker: PAVM), holds ― shares in ContraFect (Ticker: CFRXQ), holds 3.64M shares in Lucid Diagnostics (Ticker: LUCD).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+12.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lishan Aklog holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lishan Aklog
Lishan Aklog's Trading History
PAVmed
Apr 03, 2026
Chairman & CEO, Director
Uninformative Buy
―
$1.57M
ContraFect
―
Director
―
―
Lucid Diagnostics
Feb 24, 2026
CEO, Director
Uninformative Buy
―
$2.92M
PAVmed Inc
Feb 16, 2018
―
Uninformative Sell
―
$73.48M
List of latest transactions for each holding click on a transaction to see Lishan Aklog's performance on stock
You May Also Like
Lishan Aklog insider profile FAQ
What is the percentage of profitable transactions made by Lishan Aklog?
The percentage of profitable transactions made by Lishan Aklog is 50%.
What is the average return per transaction made by Lishan Aklog?
The average return per transaction made by Lishan Aklog is 12.10%.
What stocks does Lishan Aklog hold?
Lishan Aklog holds: PAVM, CFRXQ, LUCD, PAVMU stocks.
What was Lishan Aklog’s latest transaction?
Lishan Aklog latest transaction was an Uninformative Buy of ―.
What was Lishan Aklog's most profitable transaction?
Lishan Aklog’s most profitable transaction was an Informative Buy of PAVM stock on May 28, 2019. The return on the trade was 88.50%.
What is Lishan Aklog's role in PAVmed?
Lishan Aklog's role in PAVmed is Chairman & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.